Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.51 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.51 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | AGER | Q15109 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL11626916 | 0.92 | LMNA (0.46) | LMNACYP2D6L3MBTL1ADRB2ADRB1 | |
| SCHEMBL9419530 | 0.85 | THRB (0.46) | LMNAL3MBTL1KDM4ERECQLSMN1; SMN2 | |
| SCHEMBL8644617 | 0.82 | LMNA (0.50) | LMNACYP2D6L3MBTL1ADRB2ADRB1 | |
| SCHEMBL11513661 | 0.82 | USP2 (0.55) | LMNACYP2D6KDM4EMAPTTSHR | |
| SCHEMBL11513728 | 0.82 | KMT2A (0.52) | LMNACYP2D6L3MBTL1ADRB3KDM4E | |
| SCHEMBL8644621 | 0.82 | LMNA (0.50) | LMNACYP2D6L3MBTL1ADRB2ADRB1 | |
| SCHEMBL11514601 | 0.82 | TSHR (0.47) | LMNACYP2D6MAPTTSHRMEN1 | |
| SCHEMBL2108370 | 0.82 | THRB (0.46) | LMNACYP2D6L3MBTL1ADRB2ADRB1 | |
| SCHEMBL267463 | 0.82 | LMNA (0.68) | LMNACYP2D6L3MBTL1ADRB2ADRB1 | |
| SCHEMBL11950503 | 0.81 | CYP2D6 (0.49) | LMNACYP2D6L3MBTL1ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158088-B2 | Extractant compositions for co-extracting cesium and strontium, a method of separating cesium and strontium from an aqueous feed, and calixarene compounds | BATTELLE ENERGY ALLIANCE, LLC (US) | 2012-04-17 | — | — | US | claimed |
| US-20100116749-A1 | EXTRACTANT COMPOSITIONS FOR CO EXTRACTING CESIUM AND STRONTIUM, A METHOD OF SEPARATING CESIUM AND STRONTIUM FROM AN AQUEOUS FEED, CALIXARENE COMPOUNDS, AND AN ALCOHOL MODIFIER | UT-BATTELLE, LLC | 2010-05-13 | — | — | US | claimed |
| CN-101028266-B | Lung medicine-feeding preparation containing Mulinong | LUNAN PHARM GROUP CORP | 2010-05-12 | — | — | CN | claimed |
| CN-101028266-A | Lung medicine-feeding preparation containing Mulinong | LUNAN PHARMACEUTICAL GROUP CO (CN) | 2007-09-05 | — | — | CN | claimed |
| EP-0774957-B1 | AQUEOUS FOAMABLE COMPOSITION | TILLOTTS PHARMA AG (CH) | 2001-10-31 | — | — | EP | claimed |
| US-5679574-A | SOLVENT EXTRACTION IN THE PRESENCE OF A DRYING AGENT, FILTRATION, FORMATION OF AN AQUEOUS EMULSION AND COMPARISON OF TURBIDIMETRIC RESPONSE TO A STANDARD CURVE; EFFICIENCY | ENSYS ENVIRONMENTAL PRODUCTS, INC. (US) | 1997-10-21 | — | — | US | claimed |
| CN-1158565-A | aqueous foam composition | TILLOTTS PHARMA AG (CH) | 1997-09-03 | — | — | CN | claimed |
| EP-0492615-B1 | Process for producing biguanide derivative | IDEMITSU KOSAN CO (JP) | 1995-03-08 | — | — | EP | claimed |
| US-5286905-A | Heating hydrogen halide salt of phenoxyalkylamine with dicyandiamide in paraffinic hydrocarbon solvent | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-02-15 | — | — | US | claimed |
| EP-0136727-B2 | AROMATIC POLYAMIDE YARN IMPREGNATED WITH LUBRICATING PARTICLES, A PROCESS FOR THE MANUFACTURE OF SUCH A YARN, AND PACKING MATERIAL OR ROPE CONTAINING THIS YARN | AKZO N.V. (NL) | 1992-10-07 | — | — | EP | claimed |
| US-5133875-A | System and method for treating wastewater containing industrial esters | UNIVERSITY OF SOUTH FLORIDA IN BEHALF OF BOARD OF REGENTS OF THE STATE OF FLORIDA (US) | 1992-07-28 | — | — | US | claimed |
| EP-0492615-A1 | Process for producing biguanide derivative | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-07-01 | — | — | EP | claimed |
| EP-0136727-B1 | AROMATIC POLYAMIDE YARN IMPREGNATED WITH LUBRICATING PARTICLES, A PROCESS FOR THE MANUFACTURE OF SUCH A YARN, AND PACKING MATERIAL OR ROPE CONTAINING THIS YARN | AKZO N.V. (NL) | 1987-08-12 | — | — | EP | claimed |
| EP-0136727-A1 | Aromatic polyamide yarn impregnated with lubricating particles, a process for the manufacture of such a yarn, and packing material or rope containing this yarn | AKZO N.V. (NL) | 1985-04-10 | — | — | EP | claimed |
| US-4328279-A | OF THERMOPLASTIC FIBERS, SODIUM DIOCTYL SULFOSUCCINATE AND NONIONI | KIMBERLY-CLARK CORPORATION (US) | 1982-05-04 | — | — | US | claimed |
| EP-3262009-A1 | USE OF CSH-SEED MODIFIED FIBERS IN OIL FIELD APPLICATIONS | BASF SE (DE) | 2018-01-03 | — | — | EP | disclosed |
| WO-2016135182-A1 | USE OF CSH-SEED MODIFIED FIBERS IN OIL FIELD APPLICATIONS | BASF SE (DE) | 2016-09-01 | — | — | WO | disclosed |
| US-4066675-A | PSORIASIS, THROMBOSIS | MERCK & CO., INC. (US) | 1978-01-03 | — | — | US | disclosed |
| US-4031055-A | ISOTHIAZOLONE; MILDEW RESISTANCE | ROHM AND HAAS COMPANY (US) | 1977-06-21 | — | — | US | disclosed |
| US-4018802-A | SKIN DISEASES, GROWTH HORMONE STIMULANTS, THROMBUS PREVENTION, IMMUNOLOGY | MERCK & CO., INC. (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100116749-A1 | EXTRACTANT COMPOSITIONS FOR CO EXTRACTING CESIUM AND STRONTIUM, A METHOD OF SEPARATING CESIUM AND STRONTIUM FROM AN AQUEOUS FEED, CALIXARENE COMPOUNDS, AND AN ALCOHOL MODIFIER | CANX, CBX6, CALD1 | LMNA 3538/4885CYP2D6 210/4885L3MBTL1 2892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.